•
Mar 31, 2024

ImmunityBio Q1 2024 Earnings Report

Total Revenue
$40K
Previous year: $360K
-88.9%
EPS
-$0.2
Previous year: -$0.27
-25.9%
Gross Profit
-$4.52M
Previous year: -$5.92M
-23.7%
Cash and Equivalents
$170M
Previous year: $88.5M
+92.7%
Free Cash Flow
-$108M
Previous year: -$92.7M
+16.7%
Total Assets
$401M
Previous year: $343M
+16.7%

ImmunityBio

ImmunityBio

ImmunityBio Revenue by Segment